Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 3,000 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
Allergy, 2021Cutaneous and systemic hyperinflammation drives maculopapular drug exanthema in severely ill COVID‐19 patients
Mitamura Y., Schulz D., Oro S. et al.
Olink Target 96
ESC Heart Failure, 2021Identification of sex‐specific biomarkers predicting new‐onset heart failure
Raafs A., Verdonschot J., Ferreira J. et al.
Journal of Cachexia, Sarcopenia and Muscle, 2021Proteomic profiling of low muscle and high fat mass: a machine learning approach in the KORA S4/FF4 study
Huemer M., Bauer A., Petrera A. et al.
Clinical Chemistry and Laboratory Medicine (CCLM), 2021Novel severe traumatic brain injury blood outcome biomarkers identified with proximity extension assay
Fraser D., Chen M., Ren A. et al.
Nature Communications, 2021Cell-specific and divergent roles of the CD40L-CD40 axis in atherosclerotic vascular disease
Lacy M., Bürger C., Shami A. et al.
Journal of the American Society of Nephrology, 2021Comprehensive Search for Novel Circulating miRNAs and Axon Guidance Pathway Proteins Associated with Risk of ESKD in Diabetes
Satake E., Saulnier P., Kobayashi H. et al.
Journal of Allergy and Clinical Immunology, 2021Convergence of cytokine dysregulation and antibody deficiency in common variable immunodeficiency with inflammatory complications
Abyazi M., Bell K., Gyimesi G. et al.
Journal of the American Society of Nephrology, 2021Plasma Proteomics of Renal Function: A Transethnic Meta-Analysis and Mendelian Randomization Study
Matías-García P., Wilson R., Guo Q. et al.
Hepatology, 2021The Serum Proteome and Ursodeoxycholic Acid Response in Primary Biliary Cholangitis
Barron‐Millar B., Ogle L., Mells G. et al.
Journal of Cancer Research and Clinical Oncology, 2021Associations of circulating mediators of inflammation, cell regulation and immune response with esophageal squamous cell carcinoma
Camargo M., Song M., Ito H. et al.
Nature Communications, 2021The geometry of clinical labs and wellness states from deeply phenotyped humans
Zimmer A., Korem Y., Rappaport N. et al.
Biofabrication, 2021Bio-instructive hydrogel expands the paracrine potency of mesenchymal stem cells
Drzeniek N., Mazzocchi A., Schlickeiser S. et al.
Science Translational Medicine, 2021Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro
Reyes M., Filbin M., Bhattacharyya R. et al.
Olink Explore 3072/384
Cell Discovery, 2021Integrating longitudinal clinical laboratory tests with targeted proteomic and transcriptomic analyses reveal the landscape of host responses in COVID-19
Tan Y., Zhang W., Zhu Z. et al.
European Heart Journal. Acute Cardiovascular Care, 2021Predicting outcome in acute myocardial infarction: an analysis investigating 175 circulating biomarkers
Eggers K., Lindhagen L., Baron T. et al.
PLOS ONE, 2021Plasma ACE2 predicts outcome of COVID-19 in hospitalized patients
Kragstrup T., Singh H., Grundberg I. et al.
Nephrology Dialysis Transplantation, 2021Osteoprotegerin predicts cardiovascular events in patients treated with haemodialysis
Wu P., Glerup R., Svensson M. et al.
Vaccines, 2021Predictive Markers of Immunogenicity and Efficacy for Human Vaccines
Van Tilbeurgh M., Lemdani K., Beignon A. et al.
Leukemia, 2021STAT3 activation in large granular lymphocyte leukemia is associated with cytokine signaling and DNA hypermethylation
Kim D., Park G., Huuhtanen J. et al.
Neuro-Oncology Advances, 2021Plasma IL-8 and ICOSLG as prognostic biomarkers in glioblastoma
Holst C., Christensen I., Vitting-Seerup K. et al.
3195 publications
Items per page
2541-2560 of 3195 publications